Document Library
Early market shaping roadmap: novel tuberculosis vaccines: public summary 2026
Tuberculosis (TB) is the world’s leading cause of death from an infectious agent, with 10.7 million cases and 1.2 million deaths in 2024, predominantly in low- and middle-income countries (LICs and MICs). The World Health Organization (WHO) WHO Preferred Product Characteristics (PPC) for New Tuberculosis Vaccines prioritises development of vaccines to prevent pulmonary TB disease in adolescents and adults. This document is the public summary of the early market shaping roadmap for novel TB vaccines.
Code of Ethics and Conduct for Governance Officials
The Code defines the ethical principles and behavioural standards expected of all Governance Officials and guides decision‑making aligned with Gavi’s mission and values. It promotes transparency, accountability and respectful collaboration across governance roles by setting clear expectations for conduct.